Your browser doesn't support javascript.
loading
The impact of COVID-19 on people with epilepsy: Global results from the coronavirus and epilepsy study.
Vasey, Michael J; Tai, Xin You; Thorpe, Jennifer; Jones, Gabriel Davis; Ashby, Samantha; Hallab, Asma; Ding, Ding; Andraus, Maria; Dugan, Patricia; Perucca, Piero; Costello, Daniel J; French, Jacqueline A; O'Brien, Terence J; Depondt, Chantal; Andrade, Danielle M; Sengupta, Robin; Datta, Ashis; Delanty, Norman; Jette, Nathalie; Newton, Charles R; Brodie, Martin J; Devinsky, Orrin; Cross, J Helen; Sander, Josemir W; Hanna, Jane; Besag, Frank M C; Sen, Arjune.
Afiliação
  • Vasey MJ; East London NHS Foundation Trust, Bedford, UK.
  • Tai XY; Nuffield Department of Clinical Neurosciences, Oxford Epilepsy Research Group, University of Oxford, Oxford, UK.
  • Thorpe J; Nuffield Department of Clinical Neurosciences, Oxford Epilepsy Research Group, University of Oxford, Oxford, UK.
  • Jones GD; Nuffield Department of Clinical Neurosciences, Oxford Epilepsy Research Group, University of Oxford, Oxford, UK.
  • Ashby S; SUDEP Action, Wantage, UK.
  • Hallab A; Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Ding D; Biologie Intégrative et Physiologie - Neurosciences Cellulaires et Intégrées, Faculté des Sciences et Ingénierie, Sorbonne Université, Paris, France.
  • Andraus M; Institute of Neurology, Fudan University Huashan Hospital, Shanghai, China.
  • Dugan P; Department of Internal Medicine, Faculty of Medicine & Neurology and Neurophysiology Services, Deolindo Couto Institute of Neurology, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
  • Perucca P; Department of Neurology, NYU Grossman School of Medicine, New York, New York, USA.
  • Costello DJ; Department of Medicine (Austin Health), Epilepsy Research Centre, The University of Melbourne, Melbourne, Victoria, Australia.
  • French JA; Department of Neurology, Bladin-Berkovic Comprehensive Epilepsy Program, Austin Health, Melbourne, Victoria, Australia.
  • O'Brien TJ; Department of Neuroscience, School of Translational Medicine, The Alfred Hospital, Monash University, Melbourne, Victoria, Australia.
  • Depondt C; Departments of Medicine and Neurology, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia.
  • Andrade DM; Epilepsy Service, Cork University Hospital & College of Medicine and Health, University College Cork, Cork, Ireland.
  • Sengupta R; Department of Neurology, NYU Grossman School of Medicine, New York, New York, USA.
  • Datta A; Department of Neuroscience, School of Translational Medicine, The Alfred Hospital, Monash University, Melbourne, Victoria, Australia.
  • Delanty N; Department of Neurology, CUB Erasme Hospital, Hôpital Universitaire de Bruxelles-Université Libre de Bruxelles, Brussels, Belgium.
  • Jette N; Division of Neurology, Adult Epilepsy Genetics Program, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Newton CR; Institute of Neurosciences, Kolkata, India.
  • Brodie MJ; Institute of Neurosciences, Kolkata, India.
  • Devinsky O; School of Pharmacy and Biomolecular Sciences, Beaumont Hospital, FutureNeuro Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Cross JH; Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
  • Sander JW; Nuffield Department of Clinical Neurosciences, Oxford Epilepsy Research Group, University of Oxford, Oxford, UK.
  • Hanna J; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Besag FMC; Epilepsy Unit, West Glasgow Ambulatory Care Hospital, Glasgow, UK.
  • Sen A; Department of Neurology, NYU Grossman School of Medicine, New York, New York, USA.
Epilepsia Open ; 9(5): 1931-1947, 2024 Oct.
Article em En | MEDLINE | ID: mdl-39225433
ABSTRACT

OBJECTIVE:

To characterize the experience of people with epilepsy and aligned healthcare workers (HCWs) during the first 18 months of the COVID-19 pandemic and compare experiences in high-income countries (HICs) with non-HICs.

METHODS:

Separate surveys for people with epilepsy and HCWs were distributed online in April 2020. Responses were collected to September 2021. Data were collected for COVID-19 infections, the effect of COVID-related restrictions, access to specialist help for epilepsy (people with epilepsy), and the impact of the pandemic on work productivity (HCWs). The frequency of responses for non-HICs and HICs were compared using non-parametric Chi-square tests.

RESULTS:

Two thousand one hundred and  five individuals with epilepsy from 53 countries and 392 HCWs from 26 countries provided data. The same proportion of people with epilepsy in non-HICs and HICs reported COVID-19 infection (7%). Those in HICs were more likely to report that COVID-19 measures had affected their health (32% vs. 23%; p < 0.001). There was no difference between non-HICs and HICs in the proportion who reported difficulty in obtaining help for epilepsy. HCWs in non-HICs were more likely to report COVID-19 infection than those in HICs (18% vs 6%; p = 0.001) and that their clinical work had been affected by concerns about contracting COVID-19, lack of personal protective equipment, and the impact of the pandemic on mental health (all p < 0.001). Compared to pre-pandemic practices, there was a significant shift to remote consultations in both non-HICs and HICs (p < 0.001).

SIGNIFICANCE:

While the frequency of COVID-19 infection was relatively low in these data from early in the pandemic, our findings suggest broader health consequences and an increased psychosocial burden, particularly among HCWs in non-HICs. Planning for future pandemics should prioritize mental healthcare alongside ensuring access to essential epilepsy services and expanding and enhancing access to remote consultations. PLAIN LANGUAGE

SUMMARY:

We asked people with epilepsy about the effects of COVID-19 on their health and healthcare. We wanted to compare responses from people in high-income countries and other countries. We found that people in high-income countries and other countries had similar levels of difficulty in getting help for their epilepsy. People in high-income countries were more likely to say that their general health had been affected. Healthcare workers in non-high-income settings were more likely to have contracted COVID-19 and have the care they deliver affected by the pandemic. Across all settings, COVID-19 associated with a large shift to remote consultations.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pessoal de Saúde / Epilepsia / COVID-19 Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Epilepsia Open / Epilepsia open Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pessoal de Saúde / Epilepsia / COVID-19 Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Epilepsia Open / Epilepsia open Ano de publicação: 2024 Tipo de documento: Article
...